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Abstract

Introduction

Simultaneous identification of messenger RNA
(mRNA) and proteins in the same cells or tissues is a
valuable tool to help the cell biologist evaluate the cell
secretory cycle. Some cells may produce the mRNA and
delay the production of the proteins. Alternatively, the
proteins may be rapidly secreted.
Other cells may
produce both in sequence within the same time frame.
Because of this difference, some cells can only be
identified by their mRNA product. Others may have
both products.
This presentation describes a nonradioactive approach to the detection of both products
with dual-peroxidase labeling protocols in use in this
laboratory since 1983. The first detection system uses
biotinylated cRNA probes or oligoprobes in in situ
hybridization along with antisera to biotin to detect the
hybrid. The detection system is amplified by 2-3 layers
of anti-biotin, second antibody (made against the antibiotin) and streptavidin conjugated to horseradish
peroxidase. After the mRNA is detected with a blueblack substrate (nickel intensified diaminobenzidine),
the antigens are detected with immunoperoxidase
techniques and orange-amber substrate. The in situ
hybridization protocol can also be used at the electron
microscopic level. Trouble shooting and control protocols are also described. This approach has been shown
to be valuable for detection of pituitary hormones,
growth factors mRNAs and antigens.

Hybridization refers to the reaction between two
single-stranded nucleic acid molecules that bind by
means of hydrogen bonding of complementary base
pairs. Hybridization performed "in situ" refers to those
techniques that allow binding and detection of hybrids in
a cell or tissue section.
Initially, in situ hybridization was performed to
detect deoxyribonucleic acid (DNA) targets or amplified
ribosomal ribonucleic acid (RNA genes) within cell
nuclei (Gall and Pardue, 1969; John et al., 1969;
Buorgiorno-Nardelli and Amaldi, 1970). Early researchers and clinicians have also mapped the location of genes
within chromosomal preparations or nuclei (Pardue and
Dawid, 1981; Foste! et al., 1984). The early uses ofin
situ hybridization for cytoplasmic RNA involved detection of viral nucleic acid sequences within infected
tissues (Brahic and Haase, 1978; Haase et al., 1981).
Early investigators used radiolabeled complementary
cDNA or cRNA probes for the hybridization reaction.
Detection of the hybrids then involved autoradiography.
However, during the past decade other detection systems
have developed that can be as efficient as those with
radioactive labels and take only a day or two to perform.
Most of these involve the attachment of a signaling
hapten molecule such as biotin or digoxygenin to the
cDNA or cRNA probe. The detection systems for these
molecules are enhanced by sandwich techniques that
apply different layers of reactants, or enzyme reactions,
or both. The techniques can be readily applied to the
detection of both mRNA and antigens within the cells
(by dual-labeling approaches).
The purpose of this presentation will be to describe
a method for the detection of mRNAs and antigens with
dual-labeling immunocytochemistry (Childs et al., 1987,
1990, 199la,b, 1994; Kaiser et al., 1992; Lee et al.,
1993; Fan et al., 1995). We use biotinylated complementary oligonucleotide or cRNA probes to hybridize
with the cytoplasmic mRNAs. Then we detect the
probes with anti-biotin and enhance the reaction by a
sandwich technique that provides layers of biotin and
streptavidin-peroxidase (McQuaid and Allan, 1992; Fan
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et al., 1995). After the initial reaction, we can detect
the pituitary antigens by classical immunoperoxidase
cytochemistry with the use of a different colored substrate (Childs et al., 1987, 1990, 1991a,b, 1994; Kaiser
et al., 1992; Lee et al., 1993).

To maximize our ability to detect mRNA and
antigens, the protocol is applied to cells plated for 1-36
h on 13 mm glass coverslips (Thomas Scientific,
Suresdesboro, NJ; Catalog number 6672A 75) in 24 well
trays (Fisher Scientific, Houston, TX; Catalog number
08-757-156). The protocol can also be used on frozen
sections or paraffin sections. The probes used for the
hybridization are either cRNA probes (Childs et al.,
1987, 1990, 199la,b; Fan et al., 1995) or complementary oligonucleotide probes at least 30 mer long (Childs et
al., 1992 a,b, 1994; Kaiser et al., 1992; Lee et al.,
1993). They may be biotinylated by the Vector Photobiotin kit (Vector Laboratories) following kit instructions
(Childs et al., 1987; Wu et al., 1991, 1992). More
recently, we have ordered the oligonucleotide probes
commercially prepared, with Biotin attached. Alternatively, we add Biotin-DTP to the cRNA probes produced
during in vitro transcription (Fan et al., 1995).
All fixation, washing, and handling methods are run
under sterile conditions to prevent RNase contamination.
The buffer or diluent solutions are made, Millipore
filtered, and stored frozen in small aliquots. Controls
include substitution of labeled sense sequences, or
omission of the labeled probe. The protocol can be
adapted for use with dispersed cells at the electron
microscopic level.

(1) Phosphate buffered saline (PBS): 0.1 M phosphate buffer + 0.9% NaCl pH 7.2
(2) Triton X-100 (0.3%): 300 µl Triton X-100
(Sigma Chemical, St. Louis, MO); bring to 100 ml with
0.1 M PBS.
(3) EDTA (50 mM): add 1.46 g EDTA to 100 ml
of 0.1 M Tris buffer (Sigma Chemical, Catalog number
T-5030) (20 ml 0.5 M Tris + 80 ml Millipore-filtered
water), pH 8.0.
(4) Para-formaldehyde (4%): 4.0 g para-formaldehyde in 100 ml 0.1 M PBS, pH 7 .2.
(5) Acetic anhydride (0.25 %) + O.lM triethanolamine: 250 µl acetic anhydride; bring to 100 ml with
Millipore filtered water, then add 1.856 g triethanolamine, pH 8.0 (Sigma Chemical)
(6) Deionized formamide (50%) in 2X Sodium Salt
Citrate (SSC): make a 1: 10 dilution from 20X SSC with
Millipore-filtered water and add 1: 1 formamide (Sigma
Chemical, Catalog number F-7503)
(7) Sodium Salt Citrate Stock (SSC): make 20X
SSC stock by adding 3 M sodium chloride + 0.3 M
Sodium Citrate to Millipore filtered water. Make 4X
solution with a 1:5 dilution from stock 20X SSC with
Millipore filtered water
Another task is to prepare the in situ hybridiz.ation
buffer. The components are added in sequence in the
following instructions. It usually takes about a day and
it can be prepared in advance. Most of these components come from Sigma Chemical, unless otherwise
noted (see Table 1).
(1) Deionize formamide: add 1.5 g REXYN 1-300
(Fisher Scientific, Catalog number R-208) to 100 ml
formamide, stir for 45-60 min, filter through Whatman
filter paper.
(2) Combine 100 ml deionized formamide + 100 ml
4X SSC (20 ml 20X SSC + 80 ml Millipore filtered
water). The final concentration will be 50% formamide.
(3) Add 7.88 g Tris salt (0.25 M), pH 7.5, warm to
about 37°C in 1.0 ml Millipore filtered water. Dissolve
Tris.
(4) With sterile syringe and needle, add the following to the warm formamide-Tris solution: 20 g dextran
sulfate; 0.5 g bovine serum albumin (RIA grade) (Sigma
Chemical, Catalog number A-7638), 0.5 g Ficoll-400,
0.5 g Polyvinyl pyrrolidone-360, 1.0 g sodium pyrophosphate, 1.0 g sodium lauryl sulfate.
(5) Finally, add 200 µl of dissolved salmon sperm
DNA (ssDNA) to 200 ml of hybridiz.ation buffer.
(6) Aliquot into 10 ml units and store frozen (200C) in 15 ml centrifuge tubes

Preparation of solutions

Prehybridization protocol

The following list includes the solutions needed for
in situ hybridiz.ation. Table 1 provides information about
some of the major vendors that supply these reagents.

The next series of steps involve preparing the cells
for the hybridiz.ation. Several components are used to

Materials and Methods
When we first detected mRNA hybrids in whole
pituitary cells, we used the avidin biotin peroxidase
complex technique (ABC Elite, Vector Laboratories,
Burlingame, CA) (Childs et al., 1987, 1990, 199 la,b,
1992a,b, 1994; Kaiser et al., 1992; Lee et al., 1993).
We no longer use this complex to detect the biotinylated
probes because we frequently encountered high background with ABC kits used from 1993 to the present.
The early Elite kits did not have these background
problems. Thus, we now use a new five-step immunolabeling protocol that detects biotin conjugated to the
cRNA probes with anti-biotin. It was first described by
McQuaid and Allan (1992). This protocol will be
described in the following paragraphs.
Preparation of pituitary cells
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Table 1. Vendors for in situ hybridization histochemistry, including Uniform Resource Locator (URL, Internet link)
Vendor

Address

Telephonenumber

Internet

DAKO Corporation

6392 Via Real, Carpenteria, CA 93013

800-235-5763

Dimensions has a web
page devoted to DAKO
Corporation (http:/ /www2.
multinet.net/dli/dako.htm)
which has access to data
sheets

Fisher Scientific

10700 Roddey
77099

800-876-1900
800-766-7000

http:/ /www.fisherl.com

JRH Biosciences

P.O.Box 14848, Lenexa, KS 66325

800-255-6032

Sigma Chemical

P.O.Box 14508; St. Louis, MO 63178

800-325-3010

Thomas Scientific

99 High Hill Road, P.O.Box
Suresdesboro, NJ 08085-0099

99,

800-345-2100

Vector Laboratories

30 Ingold Road, Burlingame, CA 94010

800-227-6666

Road, Houston,

TX

http://www. sigma. sial.
com/sigma/sigma.html

http: / /www2. mu!tin et. net/
dli/vector.htm

Table 2. Internet Uniform Resource Locator (URL) links to courses, protocols and services in in situ hybridization
(1) Link to our protocols including the colored versions of Fig. 1 and other photographs. We will continue to
update this page as we progress. URL: http://cellbio.utmb.edu/childs/in _ situ.htm
(2) The Anderson Laboratory in situ protocol (URL: http://www.cco.ca1tech.e ... r/htmls/Big_In_situ.html)describes
non-radioactive methods for labeling frozen sections, whole mount embryos and cultured cells.
(3) This protocol (URL: http://cellbio.ucdavis.e ... mePage/Tucker/WCRDB.html describes single cell RT-PCR and
quantitative in situ hybridization for beginners.
(4) Dr. Jan Blancato (ONCOR, Inc.) gives a course in in situ hybridization. The URL is: http://www.cua.edu/
www/catc/ish.htm
(5) Exon-Intron, Inc. runs a course in in situ hybridization. The URL is: http://www.dnatech.com/insitu.htm.
(6) Paul Hough at Brookhaven National Laboratory runs an advanced in situ hybridization course. The URL is
http://www. cshl. org/ meetings/96si tu. htm.
aid penetration and several steps are used to prevent
non-specific reactions. In our protocol, the pituitary
cells are plated on glass coverslips and grown in
Dulbecco's Modified Eagle's Medium (DMEM, JRH
Biosciences, Lenexa, KS; Catalog number 56499-lOL),
and fixed in 2.5 % glutaraldehyde (in 0.1 M phosphate
buffer) for 30 min at room temperature. Then cells are
washed for 1 h in 4 changes of phosphate buffer +
4.5 % sucrose. We work under sterile conditions even
during the fixation process and store the cells no longer
than 1 week at 2-4 °C. The steps are taken to prevent
RNase contamination which would eliminate RNA from
the tissue or cells.
On the day of the hybridization, we first rinse the

fixed cells on coverlips with fresh, sterile 0.1 M phosphate buffered saline (PBS) for 5 min at room temperature, shaking. Then we treat in the following sequence
of solutions. (All of the following chemicals but the pformaldehyde came from Sigma Chemical). All steps
are done at room temperature.
(1) To aid penetration of reagents, the cells are first
treated with 0.3% Triton X-100 for 15 min at room
temperature. This is followed by washing with O.lM
PBS (twice, 3 min each, while gently shaking on a sideto side shaker).
(2) To further improve penetration and remove
associated proteins, we next treat with Proteinase K (1
µg/ml) for 15 min at room temperature.
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(3) The cells are then stabilized by postfixation with
4 % para-formaldehyde/0. lM PBS for 5 min at room
temperature. This is followed by washing with 0.1 M
PBS (twice, 3 min each, while gently shaking).
(4) To cover non-specific reactive sites, we next
treat the cells with 0.25 % acetic anhydride for 10 min
while shaking.
(5) We then treat the cells with 50% formamide/2X
SSC for 10 min while shaking the tray at room temperature. Then we continue the incubation at 37°C for 10
min. This solution prepares the cells for the hybridization buffer and helps break weak hydrogen bonds in the
non-specific linkages between the complementary probe
and the surrounding tissue. If there is a 2-3 % mismatch
in the complementary probe, the concentration of this
solution should be lowered to 40-45% to prevent breaking bonds in the specific probe-mRNA hybrid. This
lower concentration should also be used to make the
hybridization buffer. (Note that the concentration in the
buffer is 50 % in the above formulation).

one can raise the temperature of the washes. This
involves continuing the washes with reduced concentrations of SSC (2X, lX and 0.5X), 15 min each wash.
However, we have found this to be unnecessary, especially with our oligonucleotide probes.
Detection of the biotin

After the post-hybridization washes, the detection
protocol can be followed.
The detection protocol begins with a blocking step in a
solution containing proteins. They cover non-specific
sites and prevent background reactions, but they do not
react with any of the components of the detection
protocol. Therefore, we first block with 0.05 M Tris
buffered saline containing 1 % bovine serum albumin +
10% normal horse serum (Vector Laboratories) for 15
min at room temperature (pH 7 .6). Then we detect the
biotin on the hybrids with the following sequence:
(1) The cells are first treated with monoclonal antibiotin (1:30) (Dako Corp.) for 30 min at 37°C. They
are then washed with 0.05 M Tris buffered saline
(twice, for 3 min each), pH 7.6).
(2) The cells are then incubated with biotinylated
horse anti-mouse lgG (rat absorbed, Vector Laboratories), 1: 100, for 10 min at room temperature. They are
then washed with 0.05 M Tris buffered saline (twice, 3
min each). It is very important to use rat-absorbed antimouse IgG because most of these antisera will react with
rat tissues, non-specifically.
(3) The cells are incubated with a second layer of
monoclonal Anti-Biotin (1:100) for 30 min at 37°C.
Coverslips are then washed with 0.05 M Tris buffered
saline (twice, 3 min each).
(4) The cells are incubated with a second layer of
biotinylated horse anti-mouse IgG (rat absorbed) 1: 100
for 10 min at room temperature and washed with 0.05
M Tris buffered saline (twice, 3 min each).
(5) Finally, we incubate the cells with a 1:10
dilution of peroxidase conjugated streptavidin (Dako,
Catalog number P-397) for 5 min at room temperature.
The cells are then washed with 0.05 M Tris buffered
saline (twice).
At this point, the nickel-intensifieddiaminobenzidine
(DAB) is prepared by dissolving 0.45 g nickel ammonium sulfate in 30 ml 0.05 M acetate buffer, adding 1
diaminobenzidine tablet (Sigma Chemical, Catalog
number D-5905). The solution is dissolved. Then we
add 20 µl of 30 % hydrogen peroxide. The solution is
filtered on a Whatman filter paper and then added to the
cells for 6 min. The reaction product is blue-black. This
reaction cannot be improved by longer times. There is
a limited life and time-span of this solution. Therefore,
to increase signal, we vary concentrations of the probe
or other components of the detection protocol (see

Alternative pre-hybridization technique

We are currently testing pepsin digestion in lieu of
the proteinase K and have had successful results with
our cells fixed in either glutaraldehyde or para formaldehyde. The Pepsin is purchased from Sigma (Catalog
number PN6887) and is made up just before use. Two
mg of pepsin are added per ml of 0.01 N HCI. It is
stored at room temperature for no longer than two
hours. It is added to the cells for 25 min at 37°C
followed by an additional 10 min at room temperature.
Hybridization conditions

The cells are then placed in the hybridization
solutions which is 300 ng/ml of biotinylated oligonucleotide or cRNA-probe diluted in hybridization buffer (see
above). They are incubated for 12-15 hat 37°C. The
temperature of hybridization may be varied according to
the melting temperature of the probe. We have found
that a range from 36 to 42 C works for most of our
probes against gonadotropins (Childs et al., 1987, 1992
a,b) or pro-opiomelanotropin mRNAs (Wu et al., 1992).
Post-hybridization protocol

After the overnight hybridization the post-hybridization washing steps are followed. We also add an RNase
treatment step if the probe used was a cRNA (Childs et
al., 1987; Fan et al., 1995). The coverslips are first
washed with 4X SSC (three times, 15 min each; this is
done at room temperature with gentle shaking during the
last 5 min). This wash is at low enough stringency (high
salt concentration) to remove the excess unreacted probe
without removing the probe that has specifically hybridized to the mRNA. If there is background with the
reaction, higher stringency washes can be done. Also,
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a pellet which must be resuspended in the new solution.
After the diaminobenzidine step, the cells are exposed to
1 % osmium tetroxide for 30 min at refrigerator temperatures (2-4 °C). This fixes the membrane lipids and
enhances the peroxidase reaction. The cell pellets are
then embedded in Epon according to traditional electron
microscopic methods.

Dual-labeling for antigens
After biotinylated ligands, mRNA or a first antigen
is detected we use contrasting colored substrates and
immunocytochemistry to detect an antigen (e.g., pituitary hormone, growth factor, or c-fos.) The following
shows an example of the protocol that detects the
antigen. This allows us to identify the hormone content
of the cell that expresses the mRNA. The basic duallabeling techniques have been published since 1983
(Childs et al., 1983). They are outlined below.
(1) Rinse coverslips with 0.05M Tris buffered saline
(once).
(2) Block again with 0.05 M Tris buffered saline +
1 % bovine serum albumin (Sigma Chemical, Catalog
number A-7638) for 15 min at room temperature.
(3) Incubate with specific antisera to antigen in
question (diluted 1:5000-1:50,000) for 30 min at 37°C.
Wash coverslips with 0.05 M Tris buffered saline (three
times).
(4) Incubate with biotinylated goat anti-rabbit IgG
(Vector Laboratories, Catalog number BA-1000) (This
is made with 25 µl stock Biotinylated-IgG + 25 µl
normal goat serum in 2 ml of buffer). Incubate for 20
min at room temperature. Wash coverslips with 0.05 M
Tris buffered saline (twice).
(5) Incubate with 1:200 peroxidase conjugated
streptavidin (DAKO, Catalog number P-397) for 20 min
at room temperature. Wash coverslips with 0.05 M Tris
buffered saline (twice).
(6) To detect peroxidase, prepare orange-amber
diaminobenzidine. Dissolve 1 Tris buffer tablet in 15 ml
Millipore filtered water, add 1 diaminobenzidine tablet
(Sigma Chemical, Catalog number D-5905) + 12 µl
30 % hydrogen peroxide; filter on Wbatman filter paper
and use immediately. Apply to cells for 5-7 min at
room temperature. Wash coverslips with Millipore
filtered water (three times). Dehydrate, dry and mount
on slides with Permount.
Note: diaminobenzidine is eventually washed out in
water soluble mounting media, especially temporary
mounting media like glycerol. Therefore, if another
peroxidase substrate is used, that requires water soluble
media, please store the slides dry and use glycerol
ONLY for short periods of time. The best way to store
the slides is to dehydrate the tissues and use permount.
Table 2 lists Internet Uniform Resource Locator

1
Figure l. A cluster of pituitary cells, one of which is
dual-labeled for FSH-beta mRNA (black, arrows) and
LR-beta antigens (gray, L). Note that the label for
mRNA is in a linear pattern. The gray label for the LH
antigens detects them throughout the cell except on the
nucleus. Bar = 10 µm. Reproduced with permission
from Childs et al. (1994).
Discussion).
After the diaminobenzidine step, the coverslips are
washed with 0.05 M acetate buffer (twice), dehydrated,
dried and mounted to glass slides, cell side up with
Permount. A second square coverslip is mounted over
the cells. Note: This DAB reaction product is dissolved
in water soluble solutions and therefore cannot be used
with water soluble mounting media or glycerol. Therefore, use only organic solvent soluble mounting media
with it. One can view the slides for a brief period
mounted in glycerol, however eventually this will
remove the reaction product.
After the mRNA is detected with the blue-black
peroxidase substrate, the cell can be further labeled by
immunocytochemistry for its protein or antigen content.
For this we use the dual-labeling protocol with contrasting color peroxidase substrates.

Applicationsof this technique to electron microscopic
preparations
We apply the above technique to the detection of
mRNA at the electron microscopic level by leaving the

dissociated pituitary cells in suspension (Childs et al.,
1990). Then, we spin the cells down at 900 rpm after
each step. The gentle spinning is effective and creates
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Figure 2. Label for LR-beta mRNA on the surface of rough endoplasmic reticulum detected with a biotinylated cRNA
probe and avidin peroxidase (arrows). Note that the secretory granules (g) remain unlabeled. Bar = 0.25 µm.
(URL) links to courses, protocols and services in in situ
hybridization.

et al., 1994).
Fig. 1 shows dual labeling for FSH mRNA and LH
antigens (Childs et al., 1994). The cell in this figure
expresses FSH mRNA in a black linear pattern, and
Luteinizing hormone (LH) antigens, labeled orange. In
black and white, the orange label is gray and fills the
cell.
Fig. 2 shows that, at the electron microscopic level,
the label is associated with dilated profiles of rough
endoplasmic reticulum (Childs et al., 1990). This field
shows labeling for Luteinizing hormone beta subunit
mRNA on dilated rough endoplasmic reticulum (RER)
in a pituitary gonadotrope. Studies from our laboratory

Results and Discussion
The labeling for the mRNA is in dark patches or
lines in the specific cell type. This can be confirmed by
immunolabeling for the antigen in the same cell (Childs,
1987, 1991a,b, 1992 a,b, 1994; Kaiser et al., 1992; Lee
et al., 1993; Fan et al., 1995). However, there are
clearly cells that contain only the antigen or only the
mRNA (Childs et al., 1994). Thus, we have discovered
cells in different stages of their secretory cycle (Childs
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with unique sequences, however, or specificity will be
compromised.
In our hands, this technique does not give high
background. Usually the background is crystal clear and
the unlabeled cells are difficult to see without the benefit
of special optics. However, if there is background, it
is usually seen as a steel gray (or light blue) deposit all
over the field or cells. Also, it could be seen in duallabeled fields as light amber label all over the cells. In
that case, one might suspect the second labeling protocol. However, both could be at fault. And, both should
be checked.
There are several ways to reduce background.
First, one can remove one layer of the detection system
for the mRNA (an anti-biotin and a anti-mouse lgG step)
or dilute the components further. This should be done
only if the signal is strong, however. Second, one can
increase SSC washes, reducing the concentration to
O.lX. This low salt provides high stringency conditions
needed to wash out the non-specifically bound probes
that may cause the background. This is especially a
problem with the sticky cRNA probes. Caution must be
given, however, to the possibility that the washes will
wash out the probe attached in the specific hybrids.
Finally, the use of different concentrations of the
detecting reagents for the biotin (anti-biotin and streptavidin-peroxidase) will reduce background. If the signal
is strong, one can dilute both and achieve optimal
results.

(Childs et al., 1990) show similar patterns of labeling
for Follicle stimulating hormone mRNA.
Troubleshooting this protocol

The label is easy to detect in cells because of its
density and linear or patchy pattern. However, it should
not be mistaken for the metallic deposits sometimes seen
in the cells (pseudoperoxidase activity). The label in
cells that do not have amber label should be blue-black
or a purplish blue. A steel-gray background over all the
cells indicates background problems that should be
eliminated (see below).
The in situ hybridization fields should always be
quantified. Furthermore comparisons should be made
between single and dual-labeled preparations.
One
should count the percentages of labeled cells in fields
exposed only to the single labeling protocol After one
is confident of the percentages, one should then count
the percentages of mRNA-bearing cells in the duallabeling protocol. They should match. To facilitate this
comparison, we have developed a Lotus 1,2,3 or Exel
Spreadsheet that automatically calculates these percentages after we load in the raw counts (Childs et al., 1991
a,b, 1994; Lee et al., 1993). We also compare percentages of antigen bearing cells with those obtained through
single labeling. These tests are vital to insure that the
dual-labeling protocol does not interfere or add to the
detected label for either mRNA or antigens. Controls
run with the labeling protocol (see below) will also help
test the specificity of the reaction.
The labeling density for the mRNA (sensitivity) can
be improved by adding another layer of anti-biotin and
streptavidin. However, one runs the risk of higher
background (McQuaid and Allan, 1992). Also, tests of
different temperatures of hybridization may show an
optimal temperature that promotes labeling. Finally, one
can vary the concentration of probe from 0.1-100 ng/ml
for example and the reaction should increase with
increasing concentration (up to a plateau point).
cRNA probes usually are more sensitive because
they carry more biotin molecules/probe and they are
longer. Yet, they are sticky and difficult to work with.
They also require expertise in molecular biology techniques for their production. Oligonucleotide probes may
carry only one biotin although they can be engineered to
carry more. Their sensitivity may also vary with the
size and number of biotin molecules. Some low abundance mRNAs may require cRNA probes for adequate
detection.
Nevertheless, for most of our studies,
biotinylated oligonucleotide probes label expected
populations of cells at concentrations of 1-100 ng/ml.
One could also engineer several biotinylated probes
directed against different parts of the mRNA transcript.
This may increase sensitivity. All probes must react

Controls

We have controlled for interference during the dual
labeling by eliminating either the complementary RNA
probe from the first sequence or the specific antibody
from the second sequence. In each case, the resulting
labeling reflects only that which had the complete
sequence. Thus, we have proved that the first detection
protocol does not add to the label in the second (and visa
versa). Furthermore, we have absorbed the specific antibody in the second sequence with its specific antigens.
This has eliminated all second reactions and only the
blue-black label for the mRNA is visible. This not only
proves the specificity of the labeling, it proves that the
amber diaminobenzidine does not cause the blue-black
label to change color. In studies since 1983, we have
shown that the blue-black diaminobenzidine is stable, as
long as the second reaction is not prolonged (Childs et
al., 1983). This is why the rapid ABC or DAKO
immunoperoxidase kits are so valuable. If immunolabeling requires 48 hour incubation in antisera, one runs
the risk of losing all detectable reaction product during
the second incubation periods. Thus, immunoperoxidase
kits with short incubation times should be chosen.
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Summary

To summarize, this protocol has been used successfully for the detection of mRNAs in tissue sections
(McQuaid and Allan, 1992) and cell cultures (Fan et al.,
1995). It is preferred over the direct avidin detection
systems because of its sensitivity and the fact that some
avidin-containing kits produce high background. The
anti-biotin sandwich method provides flexibility and
enhancement potential along with a streptavidin solution
that works at neutral pH and gives low background
reactions.
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Discussion with Reviewers
Reviewer I: In many protocols, methanol treatment
makes a variety of cultured cells sufficiently permeable
to the probe. Your prehybridization protocol includes
proteinase K treatment "to improve penetration (of
probe) and remove associated proteins". Proteinase K is
a very active, non-specific endopeptidase, at high
concentration capable of degrading proteins into single
amino-acids. Isn't the proteinase K treatment too hazardous for epitopes to be detected in the same samples,
after the hybridization step?
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Combined immunocytochemistry and in situ hybridiz.ation
with biotinylated probes?
Author: Actually, these techniques are not purely
quantitative in that they do not allow one to detect
amounts of DNA or mRNA in a cell. Thus, "efficient"
is the operative word, rather than sensitivity. With our
system, we use concentrations of cRNA probes for
detection that are comparable to those used in autoradiographic detection protocols. If the same enzyme techniques are used in an in situ PCR reaction, the amplifying effects of the enzyme substrates allow detection of as
little as one copy of mRNA per cell.

Author: That is an excellent question.

The original
technique was for use with cRNA probes to detect LHbeta and FSH-beta mRNAs in rat pituitary cells. These
large probes (300- 500 bp) required more intense
deproteination. Therefore, we used the Proteinase K
effectively to aid penetration. At the same time, we
recognized the danger to the antigens to be detected in
the immunolabeling protocol.
Therefore, we tried
fixation in 2 % glutaraldehyde for 30 min at room
temperature before any of the hybridiz.ation steps. This
fixative gives much stronger cross-linking than any
formalin fixative because the glutaraldehyde has two
aldehyde groups that can cross link amino acids (formaldehyde has only one group).
We already knew that the anterior pituitary antigens
were preserved well in glutaraldehyde-fixed tissues.
Therefore, we were pleased when we discovered, in
1987, that the in situ hybridiz.ation protocol with proteinase K did not destroy any of the pituitary antigens used
to date. In fact, the major result was increased efficiency in the reactions. All primary antisera dilutions were
increased at least 2-fold. For example, in a recent
experiment with Growth hormone detection, the optimal
dilution of anti-GH after dual immunolabeling (two
antigens) was 1:20,000-1:40,000.
However, after in
situ hybridiz.ation, the optimal dilution of anti-GH was
1:70,000-1:80,000. These antigens are stored in granules and dilated rough endoplasmic reticulum and this
may also be a factor in their recovery. Cytoplasmic
antigens may be more labile and require less intense
deproteination.

Reviewer II: How do various fixation conditions affect
the sensitivity of the detection method. Is 2.5 % glutaraldehyde used for both light and electron microscopy
and/or when performing a dual labeling experiment?
Doesn't glutaraldehyde fixation abolish or reduce the
antigenicity of endogenous proteins when performing a
dual labeling experiment for both mRNA and endogenous proteins.?
Author: We always run comparative studies with any
new antigen or mRNA and in every case have found
increased, or equal detection efficiency when we used
glutaraldehyde. This means that we can use lower
concentrations of cRNA probes to get the same signal.
We have compared results in a variety of fixatives,
including para-formaldehyde, Bouin's, 10 % formalin
and glutaraldehyde. We just completed another comparison between formalin and 2 % glutaraldehyde and its
effects on the detection of calcium channel mRNA in
pituitary cells. The cells fixed in glutaraldehyde are
much more intensely labeled. Furthermore, the peptide
antigens are held in place by the stronger fixative and
we have a much cleaner reaction in glutaraldehyde fixed
tissues. Some of the larger glycoprotein antigens can be
detected with much higher dilutions of antisera
(1: 125,000) if para-formaldehyde is used, however the
cell fixation is not optimal. Thus, we choose glutaraldehyde and these same antigens are detected with
1:30,000-1:60,000 dilutions of their primary antisera.
One trades efficiency (more dilute antisera) for optimal
morphology. However, as stated above, we have never
encountered loss of efficiency when detecting mRNA in
glutaraldehyde-fixed tissues. Each new graduate student
is asked to do the same comparison with a new mRNA
and the conclusion has always been the same.

Reviewer I: You have discussed reasons for high
background associated with detection system for nonradiolabeled probes. However, regardless of the probe
labeling method, radioactive or non-radioactive, Jack of
probe specificity remains one of them. In our hands (35S
labeled riboprobes), the most effective way to improve
signal to noise ratio, was to use a probe that in Northern
analysis would detect a single band of a size matching
the expected mRNA size. If this condition was fulfilled,
the RN-ase treatment was found unnecessary. Do you
think that evaluating specificity of biotin-labeled probes
by Northern hybridiz.ation might be worth while?
Author: Yes, all of our biotin-labeled cRNA probes
(LH, FSH, follistatin, EGF) have been evaluated by
either Northern Hybridiz.ation or RNase protection assay
for specificity. They detected a single band. They were
used to assay pituitary mRNAs in collaborative studies.

Reviewer II: What is the major advantage of using a
biotinylated detection method? What is the major
disadvantage of using a biotinylated detection method?
Author: The major advantage is the fact that one can
achieve signal in a day, after as little as 2 hours of
incubation in the cRN A probe. The longest protocols
(with oligoprobes) are 1.5 days. It is also easily adapted

Reviewer II: The author states that non-radioactive
detection systems can be as sensitive as autoradiographic
techniques with radiolabeled probes. How can one
determine the sensitivity of the hybridiz.ation reaction
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labeling protocol and have bad some success with the
use of immunoperoxidase as the detection system for the
antigens. This protocol can be used as is for either cells
in culture or frozen sections.

to a rapid immunolabeling technique, so in less than two
days, one can detect the mRNA and the antigens. Also,
no radioactive compounds are required to add to the
growing waste. Finally, because the background is so
low (absent), one need not view or depict the cells in
dark field. Frequently, autoradiograms must be depicted
in dark field, because the background grain level is so
high in surrounding tissues. Finally, I have seldom seen
autoradiograms where the labeling grains are well
confined to the cells in question. It is impossible to
detect regional labeling in such cells. Since we know
that most cells are not filled with mRNA (100%), most
of this is artifactual spread. In the case of the nonradioactive systems, one can also get this spread,
however, it can be more readily controlled. In the case
of peroxidase, the labeling can be confined to the region
of the mRNA, where it belongs (Figure 2). There are
no real disadvantages to using any non-radioactive
detection system, since it can be adapted to In situ PCR
for the low abundance mRN As. If one has endogenous
biotin, one can use the blocking kits supplied by Vector
Laboratories. Also, there are blocking kits and reagents
available for the enzymes in the detection systems.

Reviewer II: Where does one block for endogenous
biotin, peroxidase, and/or alkaline phosphatase in the
method described.
Author: We have no endogenous biotin. We have been
using biotin-avidin detection systems in the pituitary for
over 15 years, and have never encountered any evidence
of endogenous biotin. However, if it is a problem, one
can use the blocking reagents supplied by Vector
Laboratories.
We also have been using peroxidase
detection systems since 1972. We see pseudoperoxidase
activity exhibited by red blood cells in our immunolabeling protocols.
This can be eliminated by pretreatment with hydrogen peroxide. Interestingly, we
never see this activity when running in situ hybridization
protocols.
Thus, something in our sequence must
quench it. Our control fields are so crystal clear, it is
difficult to find the cells without special optics. With
regard to alkaline phosphatase, there are blocking kits
and reagents available. However, our recent work has
shown that they are unnecessary. A recent inadvertent
proof of this happened when my technician accidentally
left out the streptavidin alkaline phosphatase in the
sequence that detected calcium channel mRNA. The
cells were exposed to an extended time in the substrate
solution. There was absolutely no reaction in these
glutaraldehyde fixed cells. Finally, our current experiments have been run on cells plated on silane coated
slides with two wells indented in each slide. One of the
wells is always a control, the other receives the biotinylated cRN A probe. We wash these slides in coplin jars,
in the same solutions. Each slide is exposed to the same
substrate solution. Not only are the controls for the
single labeling protocol completely clean (showing no
endogenous alkaline phosphatase), but the controls for
the dual-labeling protocol remain clean (showing no
endogenous peroxidase from the second protocol). The
control and experimental fields on the same slide are as
different as night and day, even if the experimental
fields contain many intensely labeled cells.

Reviewer II: Assuming that the mRN A is associated
with cytoplasmic polyribosomes and/or with RER, what
is the advantage of detecting mRNA hybrids at the
ultrastructural level? What is the major advantage of
being able to detect mRNA at the ultrastructural level,
i.e., by electron microscopy.
Author: In the pituitary, one cannot always differentiate
the cell types accurately by morphology alone. Thus
one needs a detection system that identifies the antigens
within the granules and/or the mRNA on the rough
endoplasmic reticulum. In the case of poorly differentiated pituitary cells, one might have only polyribosomes
and few storage granules. Such cells can only be
identified by their content of mRNA for the particular
hormone. Such cells are abundant among developing
gonadotropes, for example.

Reviewer II: How does one adapt this protocol for
detection of mRNA in tissue sections? Are different
fixation conditions used?

Author: We have used frozen pituitary sections with
biotinylated oligoprobes for AVP. We rapidly froze the
small tissue blocks and cut the sections with a cryotome.
Then, we fixed them in para-formaldehyde vapors.
They were then detected with an avidin detection
system. In this case, my student (Dr. Ping Wu) preferred to use streptavidin alkaline phosphatase. This
was quite successful and her papers are cited in the
reference list. We are now working on adapting the
streptavidin alkaline phosphatase technique to a dual26

